BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24018808)

  • 1. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis.
    Stewart CJ; Walsh MD; Budgeon CA; Crook ML; Buchanan DB
    Pathology; 2013 Oct; 45(6):559-66. PubMed ID: 24018808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.
    Stewart CJ; Leung Y; Walsh MD; Walters RJ; Young JP; Buchanan DD
    Hum Pathol; 2012 Aug; 43(8):1177-83. PubMed ID: 22305241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis.
    Stewart CJ; Brennan BA; Chan T; Netreba J
    Pathology; 2008 Oct; 40(6):592-9. PubMed ID: 18752126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.
    Oliva E; Sarrió D; Brachtel EF; Sánchez-Estévez C; Soslow RA; Moreno-Bueno G; Palacios J
    J Pathol; 2006 Apr; 208(5):708-13. PubMed ID: 16429393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.
    Geyer JT; López-García MA; Sánchez-Estevez C; Sarrió D; Moreno-Bueno G; Franceschetti I; Palacios J; Oliva E
    Am J Surg Pathol; 2009 Aug; 33(8):1157-63. PubMed ID: 19542870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
    Kim KR; Choi J; Hwang JE; Baik YA; Shim JY; Kim YM; Robboy SJ
    Histopathology; 2010 Oct; 57(4):587-96. PubMed ID: 20955384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
    Mhawech P; Kinkel K; Vlastos G; Pelte MF
    Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
    Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
    Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
    Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
    Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis.
    Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M
    Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis.
    Zhang C; Wang X; Anaya Y; Parodi L; Cheng L; Anderson ML; Hawkins SM
    Int J Cancer; 2018 Nov; 143(10):2505-2515. PubMed ID: 30152524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern.
    Lee SH; Kim H; Kim WY; Han HS; Lim SD; Kim WS; Kim S; Hwang TS
    Pathol Int; 2013 May; 63(5):252-9. PubMed ID: 23714252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
    N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
    Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2.
    Lai CR; Hsu CY; Chen YJ; Yen MS; Chao KC; Li AF
    J Chin Med Assoc; 2013 Nov; 76(11):629-34. PubMed ID: 23962610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.